stage IIIC esophageal cancer
Showing 1 - 25 of >10,000
Stage IIB Esophageal Cancer AJCC v7, Stage III Esophageal Cancer AJCC v7, Stage IIIA Esophageal Cancer AJCC v7 Trial
Withdrawn
- Stage IIB Esophageal Cancer AJCC v7
- +4 more
- Ferumoxytol
- Magnetic Resonance Imaging
- (no location specified)
Sep 8, 2021
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in
Active, not recruiting
- Adenocarcinoma of the Esophagus
- +5 more
- oxaliplatin
- +6 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Non-metastatic, Non-recurrent Lung and Esophageal Cancer
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +55 more
- Biospecimen Collection
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 5, 2023
Remote Telemonitoring of Patient-Generated Physiologic Health
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +171 more
- Patient Monitoring
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,
Recruiting
- Esophageal Carcinoma
- +16 more
- Educational Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +85 more
- Patient Monitoring System
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Sep 7, 2022
Pancreatic Ductal Adenocarcinoma, Colorectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Philadelphia (Adenovirus
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +37 more
- Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 2, 2021
Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma Trial in United States
Recruiting
- Advanced Colorectal Carcinoma
- +42 more
- Elimusertib
- +3 more
-
Duarte, California
- +9 more
Jan 21, 2023
Gastric Cancer Stage IIIB-IIIC Trial in Shanghai (Pembrolizumab + SOX)
Recruiting
- Gastric Cancer Stage IIIB-IIIC
- Pembrolizumab + SOX
-
Shanghai, Shanghai, ChinaRuijin Hospital
Sep 7, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +129 more
- Cyclophosphamide
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Apr 8, 2022
Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma
Recruiting
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
- +33 more
- Communication Intervention
- +2 more
-
New York, New York
- +3 more
Jun 29, 2022
Depression, Fatigue, Stage IIA Colorectal Cancer Trial in Winston-Salem, Nashville (Laboratory Biomarker Analysis, Questionnaire
Completed
- Depression
- +20 more
- Laboratory Biomarker Analysis
- +5 more
-
Winston-Salem, North Carolina
- +1 more
Jan 5, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Trifluridine and Tipiracil Hydrochloride
- Talazoparib Tosylate
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 2, 2022
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +24 more
- Capecitabine
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Mar 15, 2022
Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)
Recruiting
- Serplulimab,Gastric Cancer, Adjuvant Therapy
- Serplulimab
- +2 more
-
Shanghai, ChinaZhang Zizhen
Mar 3, 2023
Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8
Recruiting
- Advanced Gastric Adenocarcinoma
- +32 more
- Lenvatinib
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Mar 2, 2022
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in
Terminated
- Adenocarcinoma of the Esophagus
- +13 more
- oblimersen sodium
- +2 more
-
Bronx, New YorkMontefiore Medical Center
Jan 29, 2021
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +11 more
- Acupressure Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 12, 2023
Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma
Not yet recruiting
- Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
- +45 more
- Internet-Based Intervention
- +2 more
-
Manhasset, New York
- +3 more
Mar 30, 2022
HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,
Completed
- HER2-positive Breast Cancer
- +8 more
- Neratinib
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage III Gastric Cancer AJCC v8
- +30 more
- Paclitaxel
- +3 more
-
Scottsdale, Arizona
- +11 more
Apr 4, 2022
NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)
Not yet recruiting
- Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
- tereotactic body radiotherapy
- (no location specified)
Dec 1, 2023
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +22 more
- Laboratory Biomarker Analysis
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2022
Endometrial Cancer Trial in Houston (Paclitaxel, Carboplatin, Dostarlimab)
Not yet recruiting
- Endometrial Cancer
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Apr 6, 2023